Para IV presentation

June 2011 | 9 pages | ID: P404893BB82EN
MP Advisors

Abstracts

A macro study on Indian Pharma Para IV litigations – a part of our recently introduced web based application - PARA IV Plus™ . This will provide you with a broad but meaningful insight to the prevalence of Indian Pharmaceutical companies in the Para IV space

Contents

COMPANIES MENTIONED

Sun Pharma, Lupin, Dr.Reddys's, Ranbaxy, Wockhardt, Glanmark, Aurobindo, Orchid, Cadila, Torrent, Natco, Intas,